|
PCBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26385576951316E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63369318073592E-12 |
| Normal-vs-Stage2 |
7.87980014571588E-10 |
| Normal-vs-Stage3 |
8.192800E-04 |
| Normal-vs-Stage4 |
1.160590E-01 |
| Stage1-vs-Stage2 |
6.752600E-01 |
| Stage1-vs-Stage3 |
1.226320E-02 |
| Stage1-vs-Stage4 |
3.649400E-01 |
| Stage2-vs-Stage3 |
7.224000E-02 |
| Stage2-vs-Stage4 |
4.397400E-01 |
| Stage3-vs-Stage4 |
9.393000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03814742860686E-12 |
| Normal-vs-AfricanAmerican |
7.62230001338793E-09 |
| Normal-vs-Asian |
1.94497999999044E-05 |
| Caucasian-vs-AfricanAmerican |
4.192600E-01 |
| Caucasian-vs-Asian |
5.004400E-01 |
| AfricanAmerican-vs-Asian |
3.667400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66822111680176E-12 |
| Normal-vs-Female |
2.4726000003028E-07 |
| Male-vs-Female |
5.822400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.82459999834117E-09 |
| Normal-vs-Extreme_Weight |
2.55351295663786E-15 |
| Normal-vs-Obese |
1.38670000005003E-06 |
| Normal-vs-Extreme_Obese |
1.12319999967525E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.350990E-01 |
| Normal_Weight-vs-Obese |
3.049800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.451000E-01 |
| Extreme_Weight-vs-Obese |
1.240190E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.512400E-01 |
| Obese-vs-Extreme_Obese |
2.536000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.10740000003329E-06 |
| Normal-vs-Age(41-60Yrs) |
2.6155966281749E-11 |
| Normal-vs-Age(61-80Yrs) |
3.40838468559923E-14 |
| Normal-vs-Age(81-100Yrs) |
2.014200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.543600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.899600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.939600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.519000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.794200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.712800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63702384980979E-12 |
| Normal-VS-Type2 PRCC |
9.83240000529406E-08 |
| Normal-VS-KIRP CIMP |
4.51859999972548E-07 |
| Normal-VS-Unclassified PRCC |
5.371300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.176400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.940800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.616000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.679800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.737400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.886800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0699998926641E-11 |
| Normal-vs-N1 |
9.422000E-02 |
| Normal-vs-N2 |
9.334400E-01 |
| N0-vs-N1 |
4.113800E-02 |
| N0-vs-N2 |
2.379900E-02 |
| N1-vs-N2 |
5.593400E-01 |
|
|
